Boundless Bio, Inc. (BOLD) Q4 2024 Annual Earnings
BOLD·Reported March 27, 2025·Before market open
Diluted EPS came in at $-0.74.
Diluted EPS
$-0.74met estimate
Consensus: $-0.74
Financial Snapshot
Trailing eight quarters through Q4 2024
Q4 2024 Earnings FAQ
Common questions about Boundless Bio, Inc.'s Q4 2024 earnings report.
Boundless Bio, Inc. (BOLD) reported Q4 2024 earnings on March 27, 2025 before market open.
Boundless Bio, Inc. reported diluted EPS of $-0.74 for Q4 2024.
EPS beat the consensus estimate of $-0.74 by $0.00.
You can read the 10-K periodic report (0000950170-25-045725) directly on SEC EDGAR. The filing index links above go to sec.gov.